Neuropsychiatric problems in 2,500 long-term young travelers to the tropics

Journal of Travel Medicine

Volumn 7, Issue 1, 2000, Pages 5-9

  Potasman, Israel ^a   Beny, Ahuva ^a   Seligmann, Hanna ^a  

^a BNAI ZION MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

MEFLOQUINE;

ADULT; ARTICLE; DEPRESSION; FATIGUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NEUROLOGIC DISEASE; PREVALENCE; SLEEP DISORDER; TRAVEL; TROPICS; VERTIGO;

EID: 0034000133     PISSN: 11951982     EISSN: None     Source Type: Journal    
DOI: 10.2310/7060.2000.00002     Document Type: Article

References (25)

1. Handszuh H, Waters S. Travel tourism patterns. In: DuPont H, Steffen R, eds. Textbook of travel medicine and health. Hamilton: BC Decker, 1997:20-26.
2. WTO. Tourism market trends, world, 1985-1996. Madrid: WTO, 1997.
3. Monden M, Meester W. Mental decompensation during travel abroad. Ned Tijdschr Geneeskd 1994; 23:1520-1523.
4. Sauteraud A, Hajjar M. Psychotic disorders: higher incidence during travel to Asia. Press-Med 1992; 21:805-810.
5. Rishpon S. Update on malaria prophylaxis among travelers. Jerusalem: Israeli Ministry of Health, 1998:1-9.
6. Anonymous. Diagnostic and statistical manual of mental disorders. Washington, DC: American Psychiatric Association, 1994.
7. Anonymous. Statistical Package for Social Sciences. Chicago: SPSS, Inc., 1997.
8. Young D. Psychiatric morbidity in travelers to Honolulu, Hawaii. Compr Psychiatry 1995; 36:224-228.
9. Hirshon J, Eng T, Brunkow K, Hartzell N. Psychological and readjustment problems associated with emergency evacuation of peace corps volunteers. J Travel Med 1997; 4:128-131.
10. Struchler D, Handschin J, Kaiser D, Kerr L, Mittelholzer M, Reber R. Neuropsychiatric side effects of mefloquine. N Engl J Med 1991; 322:1752-1753.
11. Weinke T, Trautmann M, Held T, Weber G. Eichenlaub D, Fleischer K. Neuropsychiatric side effects after use of mefloquine. Am J Trop Med Hyg 1991; 45:86-91.
12. Phillips-Howard P, Kuile F. CNS adverse events associated with antimalarial agents. Drug Saf 1995; 12:370-383.
13. Croft A, World M. Neuropsychiatrie reactions with mefloquine chemoprophylaxis. Lancet 1996; 347:326.
14. Sowunmi A, Adio R, Odula A. Acute psychosis after mefloquine. Report of six cases. Trop Geogr Med 1995; 47:179-180.
15. Levav I, Kohn R, Dohrenwend B, et al. An epidemiological study of mental disorders in a 10-year cohort of young adults in Israel. Psychol Med 1993; 23:691-707.
16. Dawson-Saunders B, Trapp R. Basic and clinical biostatistics. East Norwalk, CT: Appleton & Lange, 1994.
17. Phillips M, Kass R. User acceptability patterns of mefloquine and doxycycline malaria chemoprophylaxis. J Travel Med 1996; 3:10-15.
18. Huzley D. Malaria chemoprophylaxis in German tourists: a prospective study on compliance and adverse reactions. J Travel Med 1996; 3:148-155.
19. Barrett P, Emmins P, Clarke P, Bradley D. Comparison of adverse events associated with use of mefloquine and combination of chloroquine and proguanil as antimalarial prophylaxis: postal and telephone survey of travelers. BMJ 1996; 313:525-528.
20. Wittes R, Sagnur R. Adverse reaction to mefloquine associated with ethanol ingestion. CMAJ 1995; 152:515-517.
21. Anonymous. Mefloquine hydrochloride. In: Reynolds J, ed. Martindale, the extra pharmacopea. London: Royal Pharmaceutical Society, 1996:468-470.
22. Palmer K, Holiday S, Brogden R. Mefloquine: a review of its antimalarial activity, pharmacokinetic properties and therapeutic efficacy. Drugs 1993; 45:430-475.
23. Patchen LC, Campbell CC, Williams SB. Neurologic reactions after a dose of mefloquine. N Engl J Med 1989; 321:1415-1416.
24. Karbwang J, White N. Clinical pharmacokinetics of mefloquine. Clin Pharmacokinet 1990; 19:264-279.
25. Derogatis L, Rickels K, Rock A. The SCL-90 and MMPI: a step in the validation of a new self-report scale. Br J Psychiatry 1976; 128:280-289.